Lixte Unveils Plan to Redefine Cancer`s Master Switch on Nasdaq
16 Sep 2025 //
ACCESSWIRE
Lixte Bio`s Summer Sees Leadership Updates, Scientific Progress
15 Sep 2025 //
PHARMAWEB
Lixte Starts Study On LB-100 For Pre-Cancerous Cell Removal
31 Mar 2025 //
GLOBENEWSWIRE
LIXTE Biotechnology Updates Progress on LB-100 for Cancer
27 Mar 2025 //
GLOBENEWSWIRE
LIXTE`s LB-100 Increases Colon Cancer Cell Recognition By Immune System
06 Jun 2024 //
GLOBENEWSWIRE